{
    "Trade/Device Name(s)": [
        "Dexcom G6 Continuous Glucose Monitoring (CGM) System",
        "Integrated Continuous Glucose Monitoring System, Factory Calibrated"
    ],
    "Submitter Information": "Dexcom, Inc.",
    "510(k) Number": "K201328",
    "Predicate Device Reference 510(k) Number(s)": [
        "K200876"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "QBJ"
    ],
    "Summary Letter Date": "October 7, 2020",
    "Summary Letter Received Date": "October 8, 2020",
    "Submission Date": "July 14, 2021",
    "Regulation Number(s)": [
        "21 CFR 862.1355"
    ],
    "Regulation Name(s)": [
        "Integrated continuous glucose monitoring system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Interstitial fluid"
    ],
    "Specimen Container(s)": [
        "Subcutaneous sensor/applicator"
    ],
    "Instrument(s)/Platform(s)": [
        "Dexcom G6 sensor/applicator",
        "BLE transmitter",
        "Receiver",
        "Mobile application"
    ],
    "Method(s)/Technology(ies)": [
        "Amperometric measurement",
        "Glucose oxidase chemical reaction",
        "Bluetooth Low Energy (BLE) data transmission",
        "Cloud-based APIs"
    ],
    "Methodologies": [
        "Continuous glucose monitoring",
        "Factory calibration",
        "Digital data communication"
    ],
    "Submission Type(s)": [
        "System",
        "Sensor",
        "Transmitter",
        "Receiver",
        "Mobile application",
        "Software"
    ],
    "Document Summary": "FDA 510(k) summary for Dexcom G6 Continuous Glucose Monitoring System including interoperable device connectivity via Partner Web APIs",
    "Indications for Use Summary": "Real-time, continuous glucose monitoring device indicated for diabetes management in persons aged 2 years and older; intended to replace fingerstick glucose testing and communicate with digitally connected devices, including automated insulin dosing systems.",
    "fda_folder": "Clinical Chemistry"
}